Serum Cytokine Levels in Major Depressive Disorder and Its Role in Antidepressant Response

키워드

참고문헌 (57)

1. Kessler RC, "Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication", Arch Gen Psychiatry, 62, pp.617~627 (2005)
2. Capuron L, "Immune system to brain signaling : neuropsychopharmacological implications", Pharmacol Ther, 130, pp.226~238 (2011)
3. Leonard BE, "The concept of depression as a dysfunction of the immune system", Curr Immunol Rev, 6, pp.205~212 (2010)
4. Leonard BE, "Stress and the immune system in the etiology of anxiety and depression", Pharmacol Biochem Behav, 54, pp.299~303 (1996)
5. Miller AH, "Neuroendocrine and immune system interactions in stress and depression", Psychiatr Clin North Am, 21, pp.443~463 (1998)
6. Song C, "Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls", J Affect Disord, 30, pp.283~288 (1994)
7. Liu Y, "Interleukin (IL)-6, tumour necrosis factor alpha (TNF-alpha) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression", J Affect Disord, 139, pp.230~239 (2012)
8. Kronfol Z, "Cytokines and the brain : implications for clinical psychiatry", Am J Psychiatry, 157, pp.683~694 (2000)
9. Yirmiya R, "Immune modulation of learning, memory, neural plasticity and neurogenesis", Brain Behav Immun, 25, pp.181~213 (2011)
10. Capuron L, "Cytokines and psychopathology : lessons from interferon-alpha", Biol Psychiatry, 56, pp.819~824 (2004)
11. Dantzer R, "Twenty years of research on cytokine-induced sickness behavior", Brain Behav Immun, 21, pp.153~160 (2007)
12. Dunn AJ, "The role of cytokines in infection-related behavior", Ann N Y Acad Sci, 840, pp.577~585 (1998)
13. Dunn AJ, "Cytokines as mediators of depression: what can we learn from animal studies?", Neurosci Biobehav Rev, 29, pp.891~909 (2005)
14. Dowlati Y, "A meta-analysis of cytokines in major depression", Biol Psychiatry, 67, pp.446~457 (2010)
15. Howren MB, "Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis", Psychosom Med, 71, pp.171~186 (2009)
16. Lieb J, "Elevated levels of prostaglandin E2 and thromboxane B2 in depression", Prostaglandins Leukot Med, 10, pp.361~367 (1983)
17. Maes M, "Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression?", Am J Psychiatry, 150, pp.1189~1193 (1993)
18. Lindqvist D, "Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity", Biol Psychiatry, 66, pp.287~292 (2009)
19. Eller T, "Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder", Prog Neuropsychopharmacol Biol Psychiatry, 32, pp.445~450 (2008)
20. Hannestad J, "The effect of antidepressant medication treatment on serum levels of inflammatory cytokines : a meta-analysis", Neuropsychopharmacology, 36, pp.2452~2459 (2011)
21. American Psychiatric Association, American Psychiatric Association Task Force on DSM-IV, "Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR", American Psychiatric Association, ~ (2000)
22. Kim H, "Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression", JAMA, 296, pp.1609~1618 (2006)
23. Kim DK, "Serotonin transporter gene polymorphism and antidepressant response", Neuroreport, 11, pp.215~219 (2000)
24. Myung W, "Serotonin transporter genotype and function in relation to antidepressant response in Koreans", Psychopharmacology, 225, pp.283~290 (2013)
25. Hamilton M, "A rating scale for depression", J Neurol Neurosurg Psychiatry, 23, pp.56~62 (1960)
26. Hamilton M, "Development of a rating scale for primary depressive illness", Br J Soc Clin Psychol, 6, pp.278~296 (1967)
27. Kato M, "Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder", Mol Psychiatry, 15, pp.473~500 (2010)
28. Leo R, "Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder : pilot observations on the effects of selective serotonin reuptake inhibitor therapy", J Clin Psychiatry, 67, pp.1760~1766 (2006)
29. Suarez EC, "The relation of severity of depressive symptoms to monocyte-associated proinflammatory cytokines and chemokines in apparently healthy men", Psychosom Med, 65, pp.362~368 (2003)
30. Wang XS, "Inflammatory markers and development of symptom burden in patients with multiple myeloma during autologous stem cell transplantation", Clin Cancer Res, 20, pp.1366~1374 (2014)
31. Freedman JE, "CD40-CD40L and platelet function : beyond hemostasis", Circ Res, 92, pp.944~946 (2003)
32. Schonbeck U, "Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture?", Circ Res, 81, pp.448~454 (1997)
33. Schonbeck U, "CD154(CD40 ligand)", Int J Biochem Cell Biol, 32, pp.687~693 (2000)
34. Neubauer H, "Newly diagnosed depression is associated with increased beta-thromboglobulin levels and increased expression of platelet activation markers and platelet derived CD40-CD40L", J Psychiatr Res, 47, pp.865~871 (2013)
35. Anisman H, "Cytokines, stress, and depressive illness", Brain Behav Immun, 16, pp.513~524 (2002)
36. Griffiths J, "Dysthymia : a review of pharmacological and behavioral factors", Mol Psychiatry, 5, pp.242~261 (2000)
37. Nierenberg AA, "Family history of mood disorder and characteristics of major depressive disorder : a STAR*D(sequenced treatment alternatives to relieve depression)study", J Psychiatr Res, 41, pp.214~221 (2007)
38. Power RA, "Dissecting the genetic heterogeneity of depression through age at onset", Am J Med Genet B Neuropsychiatr Genet, 159b, pp.859~868 (2012)
39. Fagiolo U, "Increased cytokine production in mononuclear cells of healthy elderly people", Eur J Immunol, 23, pp.2375~2378 (1993)
40. Molteni M, "Secretion of cytokines upon allogeneic stimulation : effect of aging", J Biol Regul Homeost Agents, 8, pp.41~47 (1994)
41. Paganelli R, "Humoral immunity in aging", Aging, 6, pp.143~150 (1994)
42. Simon NM, "A detailed examination of cytokine abnormalities in Major Depressive Disorder", Eur Neuropsychopharmacol, 18, pp.230~233 (2008)
43. Mikova O, "Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis", Eur Neuropsychopharmacol, 11, pp.203~208 (2001)
44. O’Brien SM, "Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy", J Psychiatr Res, 41, pp.326~331 (2007)
45. Lehto SM, "Serum chemokine levels in major depressive disorder", Psychoneuroendocrinology, 35, pp.226~232 (2010)
46. Kunkel SL, "Interleukin-8(IL-8) : the major neutrophil chemotactic factor in the lung", Exp Lung Res, 17, pp.17~23 (1991)
47. Grassi-Oliveira R, "Peripheral chemokine levels in women with recurrent major depression with suicidal ideation", Rev Bras Psiquiatr, 34, pp.71~75 (2012)
48. Sutcigil L, "Pro-and anti-inflammatory cytokine balance in major depression : effect of sertraline therapy", Clin Dev Immunol, 2007, pp.76396~ (2007)
49. de Haas AH, "Neuronal chemokines : versatile messengers in central nervous system cell interaction", Mol Neurobiol, 36, pp.137~151 (2007)
50. Madrigal JL, "Astrocyte-derived MCP-1 mediates neuroprotective effects of noradrenaline", J Neurosci, 29, pp.263~267 (2009)
51. Muller N, "The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine", Mol Psychiatry, 11, pp.680~684 (2006)
52. Akhondzadeh S, "Clinical trial of adjunctive celecoxib treatment in patients with major depression : a double blind and placebo controlled trial", Depress Anxiety, 26, pp.607~611 (2009)
53. Abbasi SH, "Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder : randomized double-blind placebo-controlled study", J Affect Disord, 141, pp.308~314 (2012)
54. Magalhaes PV, "Peripheral eotaxin-1(CCL11)levels and mood disorder diagnosis in a population-based sample of young adults", J Psychiatr Res, 48, pp.13~15 (2014)
55. Brambilla F, "Blood levels of cytokines in elderly patients with major depressive disorder", Acta Psychiatr Scand, 97, pp.309~313 (1998)
56. Brambilla F, "Interleukin-1beta and tumor necrosis factor-alpha in children with major depressive disorder or dysthymia", J Affect Disord, 78, pp.273~277 (2004)
57. Diniz BS, "Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression", J Psychiatr Res, 44, pp.917~920 (2010)

관련 논문AI추천